These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 4358224

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Studies on 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine(BL 191). I. Cyclic 3',5'-nucleotide phosphodiesterase (PDE) and the inhibitory effect of BL 191 on PDE in rat brain and heart.
    Hayashi S, Ozawa H.
    Chem Pharm Bull (Tokyo); 1974 Mar; 22(3):587-93. PubMed ID: 4371104
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effect of diabetes and insulin on the rat heart adenyl cyclase, cyclic AMP phosphodiesterase and cyclic AMP.
    Das I.
    Horm Metab Res; 1973 Sep; 5(5):330-3. PubMed ID: 4358423
    [No Abstract] [Full Text] [Related]

  • 26. Sulfamylurea hypoglycemic agents. 6. High-potency derivatives.
    Sarges R, Kuhla DE, Wiedermann HE, Mayhew DA.
    J Med Chem; 1976 May; 19(5):695-709. PubMed ID: 1271411
    [Abstract] [Full Text] [Related]

  • 27. Pyridine-3-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agents.
    Humphries PS, Bailey S, Almaden JV, Barnum SJ, Carlson TJ, Christie LC, Do QQ, Fraser JD, Hess M, Kellum J, Kim YH, McClellan GA, Ogilvie KM, Simmons BH, Skalitzky D, Sun S, Wilhite D, Zehnder LR.
    Bioorg Med Chem Lett; 2006 Dec 01; 16(23):6120-3. PubMed ID: 16973358
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of beef heart and rat brain nucleoside-3':5'-monophosphate phosphodiesterase by 3beta-14-dihydroxy-21-oxo-23-desoxo-5-beta-card-20(22)-enolide 3-acetate (AY-17,605) and structurally related compounds.
    Lippmann W.
    Experientia; 1974 Mar 15; 30(3):237-9. PubMed ID: 4363224
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cyclic nucleotide phosphodiesterases: properties, activators, inhibitors, structure--activity relationships, and possible role in drug development.
    Samir Amer M, Kreighbaum WE.
    J Pharm Sci; 1975 Jan 15; 64(1):1-37. PubMed ID: 166154
    [No Abstract] [Full Text] [Related]

  • 31. Acylureidoalkylphenylsulfonylureas with blood glucose lowering efficacy.
    Weyer R, Hitzel V.
    Arzneimittelforschung; 1988 Aug 15; 38(8):1079-80. PubMed ID: 3196400
    [Abstract] [Full Text] [Related]

  • 32. An effect of insulin on the adenosine 3':5'-cyclic monophosphate phosphodiesterase and guanosine 3':5'-cyclic monophosphate phosphodiesterase activities in the perfused Langendorff and working hearts of normal and diabetic rats.
    Das I, Chain EB.
    Biochem J; 1972 Jul 15; 128(3):95P-96P. PubMed ID: 4344014
    [No Abstract] [Full Text] [Related]

  • 33. Effect of isoprenaline on the phosphodiesterase activity of the rat heart.
    Lahiri RK, Hamid MA, Calvert DN.
    J Pharm Pharmacol; 1974 Sep 15; 26(9):731-2. PubMed ID: 4155752
    [No Abstract] [Full Text] [Related]

  • 34. New pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective PDE5 inhibitors.
    Feixas J, Giovannoni MP, Vergelli C, Gavaldà A, Cesari N, Graziano A, Dal Piaz V.
    Bioorg Med Chem Lett; 2005 May 02; 15(9):2381-4. PubMed ID: 15837329
    [Abstract] [Full Text] [Related]

  • 35. 7-Oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridines as novel inhibitors of human eosinophil phosphodiesterase.
    Duplantier AJ, Andresen CJ, Cheng JB, Cohan VL, Decker C, DiCapua FM, Kraus KG, Johnson KL, Turner CR, UmLand JP, Watson JW, Wester RT, Williams AS, Williams JA.
    J Med Chem; 1998 Jun 18; 41(13):2268-77. PubMed ID: 9632360
    [Abstract] [Full Text] [Related]

  • 36. SAR of a series of 5,6-dihydro-(9H)-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-alpha]pyridines as potent inhibitors of human eosinophil phosphodiesterase.
    Duplantier AJ, Bachert EL, Cheng JB, Cohan VL, Jenkinson TH, Kraus KG, McKechney MW, Pillar JD, Watson JW.
    J Med Chem; 2007 Jan 25; 50(2):344-9. PubMed ID: 17228876
    [Abstract] [Full Text] [Related]

  • 37. On the role of 3',5'-cyclic amp phosphodiesterase in insulin action on rat liver and adipose tissue.
    Hepp D, Menahan A, Wieland O.
    Horm Metab Res; 1969 Mar 25; 1(2):93-4. PubMed ID: 4334869
    [No Abstract] [Full Text] [Related]

  • 38. Phosphodiesterase inhibitors. Part 2: design, synthesis, and structure-activity relationships of dual PDE3/4-inhibitory pyrazolo[1,5-a]pyridines with anti-inflammatory and bronchodilatory activity.
    Ochiai K, Ando N, Iwase K, Kishi T, Fukuchi K, Ohinata A, Zushi H, Yasue T, Adams DR, Kohno Y.
    Bioorg Med Chem Lett; 2011 Sep 15; 21(18):5451-6. PubMed ID: 21764304
    [Abstract] [Full Text] [Related]

  • 39. [Derivatives of 2-mercaptobenzenesulphonylamide. IV. Synthesis and properties of some hypoglycemic agents derived from N-(4-chloro-2-mercapto-5-methylbenzenesulphonyl)urea].
    Brzozowski Z, Wójcikowski C.
    Acta Pol Pharm; 1990 Sep 15; 47(3-4):45-8. PubMed ID: 12959242
    [Abstract] [Full Text] [Related]

  • 40. Effect of SCH 15280, a new bronchodilator, on cyclic 3',5'-nucleotide phosphodiesterase activity and cyclic 3',5'-adenosine monophosphate levels in guinea pig lung.
    Kreutner W, Sherwood JE.
    Biochem Pharmacol; 1977 May 15; 26(10):951-4. PubMed ID: 193512
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.